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Abstract: Retinoic acid (RA) signaling is an important regulator of chordate development. RA binds
to nuclear RA receptors that control the transcriptional activity of target genes. Controlled local
degradation of RA by enzymes of the Cyp26a gene family contributes to the establishment of transient
RA signaling gradients that control patterning, cell fate decisions and differentiation. Several steps
in the lineage leading to the induction and differentiation of neuromesodermal progenitors and
bone-producing osteogenic cells are controlled by RA. Changes to RA signaling activity have effects
on the formation of the bones of the skull, the vertebrae and the development of teeth and regeneration
of fin rays in fish. This review focuses on recent advances in these areas, with predominant emphasis
on zebrafish, and highlights previously unknown roles for RA signaling in developmental processes.
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1. Introduction
All-trans-retinoic acid (RA) is a small molecule that is critical during developmental processes
of chordate embryos. It is of great importance that RA is available in exactly the right places and
at appropriate concentrations; therefore, a precise regulation of RA signaling is indispensable for
development. RA is thought to control the activities of more than 500 genes [1,2]. RA is a lipophilic
molecule derived from retinol (vitamin A) and is relatively short lived. It can be inactivated locally
(see below), and can either act directly on the cell that produces it (cell-autonomous and autocrine)
or on cells neighboring the source of synthesis (non-cell-autonomous and paracrine). Together,
these properties make RA well suited to act as a diffusible morphogen in several developmental
processes [3]. Disruption of RA signaling during critical developmental stages results in a wide range
of defects, for example, in the facial region, eyes, inner ear, heart, lungs, forelimbs and many other
organs [4–6].
Dietary sources of vitamin A mainly consist of retinol and retinyl ester or are ingested in the
form of carotenoids, which have to be converted to vitamin A in the intestine and other tissues [7].
Following uptake by intestinal cells, a fraction of the provitamin A carotenoids is cleaved into retinal by
the cytoplasmic protein β-carotene-15, 15′-monooxygenase (BCMO1, also known as BCO1). BCMO1 is
a key component of a regulatory network that controls the absorption of carotenoids and fat-soluble
vitamins [8]. Retinal can then be converted to retinol, which is intracellularly sequestered by cellular
retinol-binding protein type I (CRBPI) and esterified into retinyl esters for storage, mainly by lecithin
retinol acyltransferase (LRAT) [9–11]. Although most retinoids can diffuse through cell membranes
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without any carrier protein, vitamin A is mobilized from the liver by retinol binding protein (RBP)
and delivered to other organs via the circulation. In the plasma, RBP4 binds to vitamin A and this
complex is bound by transthyretin (TTR), which enhances binding in the complex. Interestingly, in fish,
RBP carries vitamin A without forming a complex with TTR [12]. At target cells, vitamin A is released
from RBP by its receptor, stimulated by retinoic acid 6 (STRA6), a transmembrane protein that is
believed to transport vitamin A through a pore into the cytoplasm [13–15].
Retinol is oxidized sequentially in two steps, first to all-trans-retinaldehyde, catalyzed primarily
by the retinol dehydrogenase RDH10. The reverse reaction, from all-trans-retinaldehyde back to retinol,
is carried out by DHRS3 [16–19]. The second step is catalyzed by retinaldehyde dehydrogenases
(ALDH1A1, -A2 and -A3), produces RA and is not reversible. In early embryonic development, the main
RA producing enzyme is ALDH1A2, while the other isoforms contribute to more elaborately regulated
patterns of RA synthesis during organ development [20]. RA signaling activity is mainly controlled
at the levels of RA synthesis and degradation. Bioactive RA is metabolized through 4-hydroxilation
into various polar compounds by either of 3 isoforms of CYP26 proteins, called CYP26A1, -B1 and
-C1, whose expression is regulated in a cell-type-specific manner [4]. CYP26 activity counteracts
the biological activity of RA [21,22], yet some of the emerging metabolites (4-oxo-RA, 4-OH-RA and
5,6-epoxy-RA) display RA-similar activities: they are able to rescue vitamin-A-deficient quails when
administered exogenously and to modulate Cyp26 gene expression, suggesting that in vivo they may
be further oxidized to inactive forms [23].
Thus, RA availability is controlled by the regulated expression of RDH10 and ALDH1A1-A3
enzymes for RA synthesis and DHRS3 and the CYP26s for reduction of all-trans-retinaldehyde and
the depletion of bioactive RA, respectively [24]. In further layers of complexity, appropriate levels
of RA signaling are provided by feedback mechanisms that couple reductions in RA signaling to
transcriptional upregulation of RDH10 and the ALDH1A isoforms [25,26]. Feedback regulation can
lead to overcompensation scenarios where the application of teratogenic levels of RA results both in
the expected gain-of-function phenotypes and loss-of-function effects due to excessive upregulation
of CYP26A1 [27]. Intracellularly, cellular RA-binding proteins (CRABP-I and -II) associate with RA
and translocate it to the nucleus or shunt available RA to CYP26s. CRABPs are able to compensate for
changes in RA synthesis and contribute to signaling robustness [28].
RA is the major and endogenous agonist for the different RA receptors (RARs), all of which
are members of the nuclear receptor superfamily [29], and are called RARα, RARβ and RARγ in
mammals. RARs heterodimerize with retinoid X receptors (RXRs) and bind DNA at retinoic acid
response elements (RAREs). Generally, in ray-finned fish, the orthologous RAR or RXR genes are
one of numerous examples of genes that exist in multiple copies, created by genome duplications
during evolution of these fish species. Each gene copy is characterized by a distinct expression
pattern indicating an individual function [30–32]. RAR/RXR heterodimers are widely expressed
in various tissues (typical examples being the head mesenchyme, the forebrain and the tail) and
knockout/knockdown studies have found evidence of widespread functional redundancies between
the different heterodimers [30,33,34]. All-trans-retinoic acid exhibits very little binding to RXR [35],
but another RA isoform, 9-cis-retinoic acid, can act as an RXR-specific ligand in vitro. However,
it remains controversial whether 9-cis-retinoic acid is a universal ligand of RXRs in vivo. In addition,
endogenous 9-cis-retinoic acid is below detection levels in most mammalian tissues with the exception
of the mouse pancreas [36]. Lastly, 13-cis-retinoic acid is a naturally occurring form of retinoic acid
that is found in blood and tissues of vertebrates, but it has no described endogenous regulatory
function [37].
In the canonical model of RA signaling, RAR/RXR dimers bind to RAREs in the absence of RA
and recruit transcriptional corepressor complexes, which themselves attract chromatin modifiers that
keep the promoter in a repressed (heterochromatin) state, so that transcription is not possible [38].
In the presence of RA, the molecule binds to RAR, which triggers conformational changes that result in
corepressor release and binding of coactivators instead [5]. Coactivators recruit diverse complexes
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of proteins that alter the chromatin structure of the target gene promoter region to an active state.
Activated RARs will then recruit the transcription machinery to the target gene promoter. RA also
recruits further RAR/RXR dimers to previously unbound RAREs by as yet unknown mechanisms.
Transcription ends when activated RARs attract coregulators that again recruit chromatin-modifying
proteins that end RA activity or when RARs are degraded by proteasomes [39]. However, it should be
noted that a small but growing number of examples has been identified in which binding of RA leads
to silencing of gene activation in developmental processes [40–42]. RA has also been shown to mediate
non-genomic effects that do not affect gene expression directly, by rapidly and transiently activating
several kinase cascades. For example, several cell types activate the p38 mitogen-activated protein
kinase (p38MAPK) in response to RA. Here, RARs have been found to be present outside the nucleus
and are often associated with the plasma membrane [39,43].
Retinoid signaling has been shown to play important roles in cellular differentiation
processes [44–47]. Many recent review articles are available that highlight specific roles of RA
in animal development: Considerable progress was made in understanding how RA acts in shaping
developing organs through the identification and subsequent functional characterization of the genes
involved in RA metabolism, retinoid transport, cellular uptake and delivery to the nucleus [19,41,48,49].
Concise overviews have been published with intermittent updates on the various roles of RA in
embryonic and male germ cell development [5,24,50,51], others outline the importance of RA signaling
gradients for patterning processes in the embryo and their elaboration by metabolic processes of RA
synthesis and catabolism [5,21]. Excellent reviews are available with a focus on the development of
individual organs, such as the heart and head [21,52,53], hematopoiesis [54], the nervous system [55]
and the maintenance of post-natal bone [56]. Lastly, particular attention has been given in recent years
to the roles of RA signaling in modulating the immune response [57–61].
Here, we review developmental processes in which either considerable progress has been made
recently towards a better understanding of the roles that RA plays or where a body of work has
accumulated that warrants a synopsis to put the new findings into perspective. We provide examples
from different areas of developmental biology, embryonic development and regeneration, on how
gradients of RA signaling are established and maintained to control cell fate decisions. The first focus
is on developing neuromesodermal precursors of the vertebrate embryo, where a rostral to caudal RA
signaling gradient is established during somitogenesis that acts on the rostral presomitic mesoderm
and the neural tube. It is antagonised by a Wnt/Fgf signaling gradient emanating from more caudal
structures and sets up a signaling front that determines whether presomitic mesodermal cells become
competent to respond to signals from the segmentation clock, a molecular oscillator, and initiate somite
formation. The same RA gradient controls cell fate decisions in the adjacent neural tube. The recurrent
theme of RA acting through a gradient is taken up again towards the end, when we examine how
proliferating osteogenic cells in the regenerating fin can undergo controlled redifferentiation to
bone-forming osteoblasts. While the somite patterning process also informs the segmented pattern of
the vertebrae that gives rise to the skeleton of the spinal column in mammals, zebrafish embryos show
that vertebrae formation can also be dependent on the notochord [62]. However, vertebral bodies
(centra) are formed by two different mechanisms in amniotes and anamniotes. In mammals and birds,
the vertebral column derives from endochondral ossification. Sclerotome-derived mesenchymal cells
migrate around the notochord and differentiate either into chondrocytes, which establish a segmented
cartilage scaffold, or into osteoblasts, which mineralize the cartilage scaffold to eventually form the
centra [63,64]. In contrast, teleost vertebral body precursors develop through intramembranous
ossification via mineralization of the notochord sheath [63–67].
As an entry point into a more detailed look at the roles played by RA in skeletal development,
we summarize the evidence that the initial steps of vertebrae formation require signaling from RA and
its local degradation by Cyp26b1. Two other processes that require RA and that shape the zebrafish
head skeleton and hard tissues are the formation of the calvaria, i.e., the bones of the upper skull,
and the development of the pharyngeal teeth. We summarize new findings from zebrafish with
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relevance to human diseases that examine the phenotypes caused by altered RA signaling on the lineage
leading from mesenchymal stem cells to bone-forming (osteogenic) cells during calvarial development.
The formation of the first teeth in zebrafish embryos is meaningful from an evolutionary perspective,
because its dependency on RA appears to be an acquired trait that is not present outside the cyprinid
family, to which zebrafish belong. Finally, some of the roles for RA in embryonic osteogenic cells are
reprised in osteoblasts of larvae and adults. However, osteoblasts are capable of dedifferentiation to
preosteoblasts, contribute to proliferating cells in the regenerating fin and then redifferentiate in the
appropriate spatial patterns to rebuild the injured fin. We summarize various essential roles that RA
plays to orchestrate the events required to lead osteoblasts through the regeneration process. We end
our review with an update on the hypothesis that RA provides positional memory in the zebrafish
caudal fin. Further evidence has accumulated now that correlates RA with position-dependent
proliferation rates rather than the position-defining activity itself.
2. RA Signaling Controls Induction and Differentiation of Neuromesodermal Progenitors
Neuromesodermal progenitors (NMPs) play a central role during body axis elongation in
vertebrates. They are a transient population of bipotential cells located in the caudal lateral epiblast
(CLE), the node-streak border (NSB) and the chordoneural hinge (CNH) and are able to differentiate
into mesodermal or neural tissue (Figure 1A) [68]. Generally, there are two populations of NMPs called
expanding- and depleting-NMPs. Expanding-NMPs are a self-renewing cell population that is only
found in amniote embryos and that is responsible for the formation of the spinal cord in the trunk
region. In contrast, depleting-NMPs form the tail spinal cord and are completely depleted at the end
of somitogenesis. In anamniote embryos, the blastopore closes after gastrulation, followed by the
formation of the tailbud. Due to these differences, anamniotes do not require expanding-NMPs and
control body elongation through depleting-NMPs [68,69].
NMPs are characterized by the co-expression of the transcription factors T/Bra and Sox2.
Their differentiation process into either neural or mesodermal cells is a complex process of regulatory
mechanisms, where the fate of cells highly depends on their position in the progenitor region [68,75–78].
In mouse embryos, the gene encoding the RA synthesizing enzyme Aldh1a2 is transiently expressed in
the posterior mesendoderm as well as in primitive streak and node cells at E7.5 and E7.75 and later,
in the pre-somitic mesoderm (PSM) and in mature somites [79,80]. A feedback mechanism between RA
and FGF signaling is a key regulator in body axis extension and somitogenesis. In this context, RA plays
a permissive role by repressing caudal Fgf8 and Wnt8 expression [38,81–83]. In chick and mouse
embryos (HH10 or E8.5–E9.5, respectively), Fgf8 negatively influences RA signaling by inhibition of
Aldh1a2 expression and activation of Cyp26a1 expression, to ensure that the caudal-most region of the
CLE and the NSB are free of RA or receive only low RA concentration (Figure 1B) [78,84–86].
The role of RA in NMP establishment and differentiation, however, only recently became
evident. Most studies that address this question are based on embryonic stem cells (ESC) that were
differentiated to NMPs in vitro [70,87,88]. To elucidate endogenous RA target genes during NMP
differentiation, mouse NMPs were exposed in vitro to a 2 h treatment with an RA concentration that
mimics physiological conditions (25 nM). This setup avoided the identification of false targets that
occurs at unphysiologically high (1 µM) RA concentrations and through the analysis of cell types,
such as ESCs, that normally are not exposed to RA in vivo. Whole-transcriptome analysis showed that
this immediately activates numerous RA-responsive genes—Cdx1, Sox2, Nkx1.2, Fgf15, Zfp503 and
Gbx2 among others—indicating an instructive role of RA. At the same time, the treatment resulted in
the repression of a large number of other targets, for example, Wnt8a, Fgf8, Id1 and Fst. Id1 encodes a
transcription factor activated by bone morphogenetic protein (BMP) signaling and Fst encodes the
BMP antagonist Follistatin. Expression studies concerning these two genes on wildtype and Aldh1a2−/−
mouse embryos revealed that RA limits expression of Id1 to mesoderm progenitors at the caudal tip of
the embryo by suppressing Id1 in the NMP niche. Similarly, RA is required to eventually extinguish
Fst in the CLE and presomitic mesoderm when somitogenesis commences. Therefore, RA separates
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both genes’ activity from the NMP area, indicating a permissive role for RA in NMP differentiation
during mouse embryonic development [70]. The simultaneous activation of genes associated with
neural (Nkx1.2, Fgf15) and mesodermal lineages (Zfp503, Gbx2) suggests that RA acts on the posterior
neuroectoderm as well as on presomitic mesoderm formation [70].
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In addition to its effects on NMP differentiation, another role of RA in NMP induction was
recently discovered [71]. Removal of all RA signaling in vitro, by cultivation of Aldh1a2−/− mouse
ESC in the absence of vitamin A, disturbed the formation of T/Bra+/Sox2+ NMP cells. The treatment
led to a downregulation of Sox2 expression, but induced T/Bra, Msgn1, Tbx6 as well as Eomes and
Mixl1, indicating a mesodermal character [71,89]. On the other hand, the addition of high levels of RA
(10 or 100 nM) to differentiating NMPs in vitro blocked mesoderm induction and promoted neural
differentiation towards pre-neural tube (PNT) identity, as evidenced by the expression of Sox2, Sox1 and
Nkx1.2 [71,87,90,91]. These results suggest that mesodermal identity (T/Bra+/Tbx6+/Cdx−) is established
in the absence of RA signaling, the induction of NMP identity (T/Bra+/Sox2+) is mediated by low
levels of RA and high levels of RA induce pre-neural identity (Sox2+/Nkx1.2+) [71,77]. Considering the
consequences of these findings for the in vivo system, it is assumed that a rostral-to-caudal gradient of
RA signaling influences the induction and positioning of distinct trunk progenitors [71]. The gradient
is established by RA produced in the CLE, the PSM and the somites and by Cyp26a1 counteracting from
the distal notochord and CNH (Figure 1B) [77,80]. To generate a feedback mechanism that regulates
the outcome of NMP differentiation, mesoderm markers Msgn1 and Tbx6, themselves activated by
Wnt signaling and T/Bra, mediate the upregulation of Aldh1a2 to increase RA synthesis, leading to the
repression of T/Bra and the activation of Sox2 and finally, to neural differentiation (Figure 1C) [92–94].
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Another component of RA signaling regulation are the genes of the Cdx family. These encode
homeobox transcription factors and play a developmental role in axis elongation. Their primary region
of expression is in the primitive streak and later, in development in the tailbud of the embryo [95,96].
To study their role in NMPs, mouse stem cells lacking all three paralogous Cdx genes (Cdx1,2,4−/−)
were created and cultivated in NMP-inducing conditions [71]. This resulted in strong induction of
Aldh1a2 expression, significant downregulation of Cyp26a1 expression and the loss of Wnt3a and
Fgf8 expression—circumstances that would promote neural tissue formation. On the other hand,
the inhibition of RA signaling in Cdx1,2,4−/− cells by treatment with the pan-RAR inverse agonist BMS493
resulted in mesodermal cell formation. However, neither treatment led to the differentiation of NMP
cells, suggesting that Cdx genes are required to act on Wnt, FGF and RA signaling to achieve the correct
RA levels that are needed to promote the induction of NMPs and their subsequent differentiation
(Figure 1B). In contrast to mice, RA is not required for extension of the body axis in zebrafish, an
organism that is lacking expanding-NMPs. It seems that the repressive effect of RA on caudal Fgf8 is
only acting in expanding-NMPs and, therefore, restricted to higher vertebrates [71]. These differences
demonstrate that caution is advised when transferring knowledge achieved from one model organism
to another.
RARs play important activating or repressing roles—strictly depending on local levels of RA,
—in the differentiation process of NMPs to unsegmented PSM and finally, to mature somites. RARβ
and RARγ are expressed in the caudal tail and trunk area in mammals [5]. In Xenopus embryos,
the predominant isoform expressed throughout the entire caudal region of the embryo, including PSM
and CNH, is rarγ2. This receptor acts as both an activator and a repressor [72]. In the transition region,
where PSM cells are differentiating towards somitic mesoderm, the presence of RA is indicated by
aldh1a2 expression. Here, Rarγ2 acts as an activator to promote somitomere differentiation [72,97].
However, in the areas of unsegmented PSM and CNH cells, RA is absent or present at low concentrations
owing to cyp26a1 expression. This allows Rarγ2 to act as a repressor to maintain the pool of mesodermal
progenitor cells (Figure 1B). A potential target that is repressed by Rarγ2 might be ripply2, a repressor
of tbx6; therefore, promoting tbx6 expression [98,99]. Similar results were obtained in a study that
differentiated mouse ESCs via Wnt pathway activation [100]. Here the pan-RAR inverse agonist
AGN193109, which stabilizes the heterodimeric complex of RA receptors (RAR/RXR) with their
transcriptional co-repressors, was applied to inhibit RA signaling during ESC differentiation, beginning
at a differentiation stage that corresponds to cells from the CLE. This promoted the formation of
the paraxial mesoderm, characterized by the upregulation of the gene markers Tbx6 and Msgn.
A continued treatment with the inverse agonist eventually repressed the maturation of PSM into the
somitic mesoderm. This suggests that RARs function in epiblast and early mesoderm progenitor
cells—areas where RA is absent—to promote their differentiation into paraxial mesoderm lineage [100].
In contrast to that, rarβ2 expression is sensitive and responsive to RA. This is the receptor
subtype most strongly downregulated by pan-RAR inverse agonist AGN193109 and correspondingly
upregulated in response to a treatment with the pan-RAR agonist TTNPB. Initiation or maintenance of
rarβ2 expression is dependent on Rarα/γ, as a knockdown of either of those two receptors causes the
loss of rarβ2 expression [73]. In Xenopus, this RA receptor is active in mature somites and its loss leads
to the rostral expansion of unsegmented PSM markers (tbx6, msgn, fgf8) and also shifts the expression
domains of somitomere markers (ripply2, mespa) rostrally. As a result, fewer but larger somites develop
that lack distinct boundaries and chevron morphology. Therefore, in Xenopus, RA activates Rarβ2 in
the trunk to regulate somitogenesis, while rarγ2 is expressed in the RA free tail area, sustaining the
PSM and NMP cell population [72,73] (Figure 1B).
3. Initiation of Vertebrae Formation in Zebrafish Relies on Precisely Regulated RA-Signaling
The early development of the vertebral column has been shown to be dependent on precise
RA-signaling in both mammals and fish [61,68–71]. The vertebral column is a segmented axial
supporting structure that consists of alternating vertebral bodies (centra) and intervertebral discs.
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In tetrapods, the skeletal elements of the vertebral bodies develop from sclerotome-derived cells
by endochondral ossification [72–74]. In contrast, vertebral bodies of teleosts develop through
intramembranous ossification in two steps. First, vertebral body precursors (chordacentra) form
through segmented mineralization of the notochord sheath by cells of the underlying notochord,
called chordoblasts [75–80]. Subsequently, sclerotome-derived cells are recruited around the notochord
sheath, which differentiate into two different types of osteoblasts: One class of osteoblasts is located
in the middle and on the anterior and posterior edges of the chordacentra and is responsible for the
secretion and mineralization of extracellular bone matrix to form the surrounding centra. A second
type of osteoblasts has been identified in medaka that is situated within the intervertebral regions
and is involved in the deposition of the collagenous matrix of the extra elastica, thus preventing
mineralization [63,101,102]. Excess RA could lead to a transition of the collagenous matrix depositing
osteoblasts to matrix mineralizing osteoblasts/osteocytes. However, this hypothesis remains to be tested.
Several studies suggest that the segmentation process and formation of these chordacentra is
dependent on spatially and temporally distinct gene expression and patterning mechanisms that are not
determined by the intrinsic segmentation clock [62,102–104]. In the earliest stages of zebrafish vertebrae
development, chordoblasts are uniformly distributed over the collagenous notochord sheath [102,105].
At the onset of chordacentra formation, the expression of chordoblast markers (like col2a1a and
col9a2) is downregulated in an alternating, ring-shaped pattern, beginning anteriorly and sequentially
moving posteriorly along the axis [102,104–106]. Concomitantly, expression of entpd5a, a marker for
biomineralizing activity in zebrafish [107], is upregulated in the same cells. Ultimately, osteoblasts are
recruited to the mineralized sheath domains to form the vertebral bodies [102,104].
In zebrafish, the onset of entpd5a-expression and mineralization of the chordoblasts is dependent
on Notch-signaling as well as precisely regulated RA-signaling [102,104]. While an excess of RA leads to
an expanded, stronger and often even fused expression of entpd5a along the anteroposterior notochord
axis, inhibition of RA-synthesis using the Aldh-Inhibitor DEAB abolishes entpd5a expression and
prevents the reiterative axial mineralization [104]. In Japanese flounder, Paralichthys olivaceus, treatment
with an excess of RA similarly induces the narrowing and fusion of centra, combined with a complete
loss of notochord and intervertebral tissues within fused centra [108]. The repetitive, RA-sensitive areas
in zebrafish are precisely defined through a negative feedback mechanism, in which RA is thought
to activate expression of both cyp26b1 and entpd5a. The immediate activation of cyp26b1 might drive
a fast degradation of RA (the exact source of which is not currently known), thus impeding RA to
spread into adjacent, prospective intervertebral regions. This, in turn, might be a crucial mechanism for
the establishment of alternating zones of mineralizing and non-mineralizing, cartilage-like domains.
Accordingly, expression of cyp26b1 along the notochord is strongly and rapidly upregulated after
addition of excess RA and eliminated upon DEAB-treatment, indicating regulation by RA [104].
Mineralizing chordoblasts in zebrafish larvae reduce collagen 2 production over time, as indicated
by reduced col2a1a-expression. This downregulation is mimicked by treatment with RA at earlier
stages of development also and extends along the entire anteroposterior notochord axis, including the
prospective intervertebral areas, and results in overall mineralization [104,106]. In contrast, complete,
as well as chordoblast-specific, inhibition of RA-signaling results in an evenly distributed col2a1a
expression and at the same time, loss of cyp26b1-signaling and mineralization [104]. Considering the
reduced matrix production in combination with the morphological changes from roundish-compact to
more stellate-like-shaped chordoblasts, a reduction of endoplasmic reticulum and an, overall, slightly
thinner notochord sheath [104], the impact of RA on chordoblasts is reminiscent of the effects of RA
on osteoblasts and preosteocytes during intramembranous bone formation (see below) [109–112].
Taken together, RA is involved in orchestrating the repeated pattern along the anteroposterior
notochord axis and simultaneously regulates the first steps towards centra development. Future
studies should address the question if chordoblasts are also involved in centra formation in other
vertebrates [104] and, therefore, if the molecular mechanisms of the two different ossification processes
are conserved in amniotes and anamniotes. Even though centra in tetrapods are formed by endochondral
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ossification of sclerotome-derived cartilaginous templates on the outer surface of the notochordal
sheath, a simultaneous contribution of chordoblasts from the inner side of the notochordal sheath has
not been addressed to date [104].
4. RA Controls Cell Fate Determination during Calvarial Bone Development
RA signaling plays important roles during the development of the vertebrate skull. This is
exemplified by various calvarial malformations and diseases that are associated with RA-signaling
disorders [111,113–116]. The cranium represents the upper part of the skull that encloses and protects
the brain and is divided into the cranial base and the calvarium. The calvarial bones are joined
through sutures and, as they are made up of flat bones, arise through intramembranous ossification.
During this process, mesenchymal stem cells (MSC) differentiate into osteoblasts, and subsequently,
to preosteocytes and osteocytes, which together compose an aggregation of osteogenic cells [109,110,117]
(Figure 2A). MSCs can also enter a chondrocyte- or a odontoblast-fate, all of which are regulated by
Runx2 [118–120]. In addition, a complex network of interactions with components of several other
signaling pathways, like FGF-, BMP-, Wnt- and thyroid hormone-signaling pathways is necessary for
accurate linage commitment and cell differentiation during bone development [118–128]. While bone
forming osteoblasts are of cuboidal shape and important for the secretion of non-mineralized bone
matrix (osteoid), preosteocytes stimulate matrix mineralization and assume a shape that is more similar
to osteocytes. Eventually, mature osteocytes are located in lacunae, embedded in the mineralized bone
matrix with a stellate-like shape and long cell protrusions [109,110]. The maintenance and remodeling
of bone requires the activity of osteoclasts—multinucleated cells of hematopoietic origin [129]—that
are believed to be in crosstalk with osteoblasts and osteocytes [109,130–132].
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4.1. Elevated RA-Signaling Leads to Premature Osteoblast to Preosteocyte Transition
Human patients carrying a null or hypomorphic mutation in the gene encoding the RA-degrading
enzyme CYP26B1 exhibit seemingly contradictory craniofacial anomalies like calvarial bone hypoplasia
(reduced formation and fragmentation of bone) and craniosynostosis (premature ossification of sutures),
respectively. Recent findings have started to unravel the mechanisms behind these developmental
defects [111,112,133]. Similar to the human hypomorphic patients, the hypomorphic cyp26b1 zebrafish
mutant stocksteif (sst) also displays premature fusion of calvarial sutures through premature suture
matrix mineralization. Osteoblasts normally reside at the osteogenic fronts of growing calvaria
and later, within the sutures. After suture formation, cyp26b1 expression is faintly detectable at
the edges of the calvarial plates, which is consistent with observations in newborn mice [111]
(Figure 2B). However, in zebrafish sst mutants or after treatment with RA shortly before suture
formation, premature synostosis (fusion) of the coronal suture initiates bilaterally at the edges of the
frontal and parietal calvarial plates, which coincides with sites of cyp26b1 expression in the wildtype
condition [111]. Furthermore, expression levels of the osteoid collagen genes col1a1 and col10a are
reduced in sutural osteoblasts of zebrafish sst mutants and the morphology of these cells has shifted
from an osteoblastic globular shape towards a more (pre-) osteocyte stellate-like shape [111]. Treatment
of murine MC3T3 preosteoblasts with RA also leads to a dose-dependent reduction of osteoblast marker
expression, while expression-levels of osteocyte markers are progressively upregulated. Since cell
number, proliferative activity and apoptosis of sutural cells in sst mutant zebrafish are not significantly
altered, these observations suggest that cyp26b1 hypomorphic defects result from a loss of osteoblastic
characteristics, especially the production of matrix osteoid at the edges of the calvarial plates, and a gain
of (pre-) osteocyte characteristics of sutural cells, which is accompanied by premature mineralization.
Accordingly, partial loss of cyp26b1 activity causes coronal craniosynostosis through accelerated
osteoblast to (pre) osteocyte transition [111].
Human CYP26B1 null patients and Cyp26b1−/− homozygous mice exhibit fragmentated calvarial
bones, a seemingly opposite cranial defect to those occurring in zebrafish cyp26b1 hypomorphic
mutants [111,112,114]. Comparable calvarial fragmentation phenotypes have been induced in zebrafish
larvae treated with exogenous RA during early calvarial plate development, which results in a reduction
in bone formation at the calvarial osteogenic fronts and in the thickness of calvarial plates [112]. This is
consistent with findings obtained in mice that were fed vitamin A, which resulted in less dense calvarial
bones accompanied with overall reduced bone areas [116]. Observations of the calvarial plates of
wildtype zebrafish larvae and mice revealed cyp26b1 expression in central parts and on the outer
surfaces of the calvarial plates, while the expression of aldh1a2 is largely restricted to meninges cells
underneath the calvarial plates and close to the active osteogenic fronts [112,134,135]. This indicates
that RA-signaling is active in areas of calvarial growth, as bone formation proceeds preferentially at
the inner calvarial surface during vertical growth, and reduced RA-signaling in areas where calvarial
growth is diminished.
Increased levels of RA have no effects on the number of osteogenic cells in zebrafish, neither around
the coronal suture of cyp26b1/sst mutants nor at the osteogenic fronts after RA-treatment [111,112].
However, osteogenic cells, particularly at the calvarial tips, change in shape to flat and elongated forms,
while bone-lining cells downregulate the expression of osteoblast-markers in favor of preosteocyte
markers [112]. Thus, similar to the coronal suture, RA-treatment triggers the premature osteoblast to
preosteocyte transition at calvarial osteogenic fronts.
The likely cause of calvarial plate fragmentation in RA-treated zebrafish is an active loss of
mineralized matrix. Calvarial fragmentations are associated with high activity of bone-resorbing
osteoclasts [112] and likewise, in mice fed excess vitamin A, the number and activity of osteoclasts
increases on the inner, endocranial surface of calvarial bones [116]. Excess vitamin A causes an
enlargement of blood vessels and an increase of cells positive for Icam1, a key endothelial molecule
involved in active recruitment of osteoclast precursors, in the thoroughly perfused dura mater
membrane that lies beneath the osteoclast-rich endocranial bone surface. As osteoclast precursors
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originate from hematopoietic cells of the monocyte/macrophage line [136], vitamin A is likely to
increase adhesion and transendothelial migration of osteoclast precursors [116].
During normal bone remodeling, osteogenic cells can regulate the activity of osteoclasts and
vice versa through an increased production of stimulators or inhibitors [137]. These are secreted
or cell surface-tethered cytokines or bone matrix components that serve as ligands to osteoblast- or
osteoclast-bound receptors and result in enhanced bone formation or resorption [112,137]. Promotors
and inhibitors from osteoblasts include M-CFS, MCP-1, RANKL, LPA and OPG, Ephrin B2, SEMA3A,
respectively, while CC3, EPHB4, CTHRC1 and ATP6V0D2, SEMA4D, sclerostin, miR-214-3p represent
known promotors and inhibitors from osteoclasts, respectively [137]. Observations in mice and
zebrafish after vitamin A/RA-treatment revealed a strong physical association between preosteocytes
and osteoclasts on the endocranial surface of the calvarial plates, supporting the notion that these
two cell types interact with each other [112,116]. As in the coronal suture and the calvarial osteogenic
fronts, premature osteoblast to preosteocyte transitioning is strongly prominent after RA-treatment at
sites of calvarial fragmentation. Thus, more osteoclasts can be activated and recruited. This indicates
that preosteocytes play an essential role during the RA-induced and osteoclast-dependent calvarial
fragmentation [112].
In the osteoclast-deficient pfeffer mutant [138,139], treatment with RA fails to induce bone
resorbing activity or the fragmentation of frontal plates, while the expression of genes encoding for
osteoclast-stimulating ligands in preosteocytes is induced in the same way as in wildtype zebrafish [112].
However, RA-treatment of zebrafish after targeted ablation of osx-positive osteogenic cells [140],
which includes osteoblasts, neither leads to calvarial fragmentations nor to an upregulation of genes
encoding for osteoclast-stimulating ligands. Hence, RA acts on the osteogenic cell lineage to attract
osteoclasts. The finding that osteogenic cells are the primary target of RA-signaling is further supported
by the observation that the RA-target gene cyp26b1 [141] is expressed in osteogenic cells rather than in
osteoclasts [112]. In conclusion, RA-signaling influences osteoclasts not directly, but via osteogenic
cells during calvarial bone resorption.
Taken together, the seemingly contradictory cranial developmental defects (craniosynostosis
versus calvarial bone hypoplasia and fragmentation) observed after exposure to elevated RA-levels
can be explained by the RA-induced dose- and stage-dependent differentiation of matrix-producing
osteoblasts to mineralizing (pre-) osteocytes [111,112]. While the reduced calvarial size results from a
decrease in osteoid production due to a premature differentiation from osteoblasts to mineralizing
preosteocytes, the calvarial fragmentation is caused by an increased number of preosteocyte-stimulated
osteoclasts. In cyp26b1 hypomorphs, Cyp26b1 levels are still sufficient for the adequate horizontal
growth of the frontal calvarial plates, while the elevated RA-level at the sutures leads to the appearance
of prematurely differentiated (pre-) osteocytes and hence, to premature suture matrix mineralization and
calvarial fusion [111,112]. This might explain why cyp26b1 amorphs do not display craniosynostosis,
as the frontal and parietal calvarial plates are reduced in size and, therefore, not able to form a
proper suture.
4.2. RA-Signaling and Ezh2 Act in Opposition for Calvarial Bone Lineage Commitment
During early calvarial bone development, RA signaling and the histone methyltransferase
Ezh2 (enhancer of zeste homolog 2) are required to be active simultaneously but with opposing effects
for early calvarial bone lineage commitment [142]. The Polycomb Repressive Complex 2 (PRC2)
is a multi-protein complex and epigenetic regulator that requires RA for recruitment to specific
genes [42,142,143]. EZH2, the catalytic component of PRC2, mediates the trimethylation of histone 3
on lysine 27 (H3K27me3), which leads to transcriptional repression of target genes and is required for
neural-crest-derived cartilage and bone formation [142,144,145]. Mutations in the human EZH2 gene
cause Weaver syndrome, which is characterized by overgrowth, advanced bone age and craniofacial
defects, like domed heads and smaller mandibles [142,146–149]. Conditional mutation of Ezh2 in
mouse (further referred to as Ezh2 mutant) cranial mesenchymal stem cells prior to skull bone cell fate
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selection in vivo revealed a stage-specific and transient role of Ezh2 for proper skull bone development.
Ezh2 mutant mice displayed decreased craniofacial bone volume and size, but almost no effects on cell
proliferation, cell survival and specification of early calvarial bone precursors [142]. Instead, Ezh2 is
required for the commitment to an osteoblast-fate, as the number of OSX-positive osteogenic cells is
strongly reduced. These phenotypes are highly reminiscent of the effects caused by hypervitaminosis
A or treatment with vitamin A or RA in humans, mice and zebrafish, respectively [111,112,114,116].
Further experiments showed that RA gavage leads to an upregulation, and RA-signaling inhibition
to a reduction, of Ezh2 expression [142]. In conclusion, both conditional Ezh2-mutation and elevated
RA-signaling cause the reduction of OSX-positive osteogenic cells and thus calvarial bone development,
while RA directly regulates Ezh2 expression (Figure 2A). This mode of action can be described as an
“incoherent type-1 feedforward model” (I1-FFL), where two arms act in opposition, while one positively
regulates the other [150]. In this case, RA signaling positively and EZH2 negatively regulate the
expression of anti-osteogenic factors to stimulate calvarial bone formation. RA signaling inhibition in
Ezh2 mutant mice leads to a partial rescue of the parietal and occipital bones as well as OSX expression,
thus demonstrating that simultaneous inhibition of the positive and negative arm of the I1-FFL is
able to partially rescue posterior calvarial bone formation [142]. In a candidate approach to identify
anti-osteogenic factors regulated by EZH2 and RA, HoxA1, HoxC8 and Hand2 were found to exhibit the
most notable increases in Ezh2 mutant mice and were also significantly upregulated after RA exposure.
Furthermore, concurrent application of RA to Ezh2 mutant mice considerably increases the expression
levels of these anti-osteogenic factors, whereas simultaneous RA-inhibition in Ezh2 mutants reduces
and thus re-establishes the number of anti-osteogenic factor HOXC8-positive cells in the parietal
bone primordia [142]. Thus, stage-specific Ezh2 expression and tight control of RA-signaling levels
are required to synergistically regulate the expression of anti-osteogenic factors and hence to ensure
accurate calvarial bone lineage commitment.
5. RA Controls the Development and Number of Pharyngeal Teeth in Zebrafish
A well-documented effect of RA in mammalian tooth development is to antagonize hard tissue
mineralization, but there is no in vivo model to support a more basic role in tooth formation [151].
However, examining the roles of RA in zebrafish tooth formation illuminates how evolutionary
modifications of RA-mediated gene regulation can facilitate diversity in vertebrate dentition. The family
of cyprinids, of which the zebrafish is a member, only develop pharyngeal teeth and their main tooth
row generally has five teeth. The majority of ray-finned fish (actinopterygians) develop either oral
teeth, which are placed around the mouth opening, or pharyngeal teeth, which are situated on the
fifth ceratobranchial bone in the back of the pharynx, or both. RA has been shown to fine-tune tooth
number at a microevolutionary scale within this taxonomic group. This idea is supported by various
observations: There is variation in tooth number in a few cyprinid species that exist with either four
or six teeth [152,153] and RA-treatment in goldfish, a cyprinid with four teeth, produces an extra
tooth [154]. Also, RA-treated zebrafish embryos will frequently develop a sixth tooth in the main
row of teeth. This phenotype is also observed in heterozygous zebrafish of the stocksteif (sst) mutant,
which harbor a mutation in cyp26b1, which causes a physiologically more subtle elevation of RA
concentration [154]. The Mexican tetra (of the order Characiformes), a close relative of zebrafish
(Cypriniformes), and medaka, a more distantly related species in the beloniform order, differ from
zebrafish in possessing oral teeth in addition to pharyngeal teeth. Surprisingly, in these species,
the formation of both types of dentition is independent of RA. It is likely that RA-induction of teeth in
Cypriniformes is an evolutionary-derived trait that is correlated with a shift of aldh1a2 expression as a
precondition to regulation of pharyngeal tooth development. This newly gained dependency on RA
may have played a role in the evolutionary loss of oral teeth in zebrafish and all other cyprinids [155].
How does RA control tooth number in cyprinid fish? The first pair of teeth (named 4V1),
differentiates at 48 hours post fertilization (hpf). Its appearance is followed by the formation of a pair
of neighbors, 3V1 medially and 5V1 laterally. 4V1 is replaced by 4V2 at 12 days post-fertilization
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and in adult fish, the fifth branchial arch has grown to accommodate eleven teeth in a stereotypical
arrangement, with five teeth positioned in the ventral main row, four teeth in a medio-dorsal row and
two teeth in the most dorsal row [156]. Tooth development through “first generation teeth” like 4V1 is
representative for many other families of actinoptrygians. Where it occurs, the first tooth has been
proposed to determine the formation of the remaining teeth of a row.
At the time of first tooth bud formation aldh1a2 and the RA receptors raraa and rarab are expressed
broadly in the ventral pharynx, but aldh1a2 expression is excluded from the developing 4V1 tooth
bud mesenchyme. Furthermore, tooth bud mesenchyme expresses cyp26b1 to protect itself from
RA [154]. An experimental increase in RA signaling activity expands the expression of markers of the
dental (dlx2, lhx6) and pharyngeal mesenchyme (pitx2a). The consequences are a widened expression
domain of tooth markers in the ventral fifth ceratobranchial arch that generates an expanded domain
competent for tooth induction [154]. Induction of 4V1 is dependent on sequential signaling first by
RA and then, FGFs between 43 and 49 hpf [155,157] and has been shown to determine the formation
of the remaining teeth of a row: Application of antagonists of either RA- or FGF signaling, after 4V1
is induced, suppresses the development of the adjacent germs of 3V1 and 5V1 [158]. Timed early
treatments with exogenous RA from 24 to 36 (or 52) hpf also induces ectopic 4V1 teeth in more anterior
and dorsal positions of the pharynx, where teeth are normally absent [159]. Such ectopic 4V1 tooth
germs initiate their own new rows of teeth, starting with neighboring 3V1 and 5V1 teeth. 4V1 expresses
Fgfs (fgf4 and/or fgf3) and Fgf receptors are expressed in pharyngeal arches of both wildtypes and
RA-treated embryos with ectopic 4V1 tooth germs [157,158]. FGF signaling plays an activating role
in tooth formation; therefore, Fgfs are good candidates for initiating dental rows in zebrafish [160].
The epistatic relationships between RA and FGF signaling are not fully resolved, as RA does not
rescue early tooth markers in the absence of FGF signaling and overexpression of fgf10 is ineffective in
rescuing tooth development when RA is absent, even though fgf10 is sufficient to induce some ectopic
teeth [155].
Like RA, induced deficiency of thyroid hormones also generates supernumerary teeth anterior
to the beginning of a tooth row [161], which may guide future explorations into the underlying
mechanisms. Thyroid hormone receptors and RARs share RXRs as heterodimeric partners, which is
thought to explain why RA and thyroids repress the activation of each other’s target genes in craniofacial
neural crest cells (from which the tooth-producing odontoblasts derive) [162–164]. It is conceivable that
a reduction of thyroid hormones allows a more ready activation of RA signaling [161]. Further evidence
for cross-talk between RA and thyroid hormone signaling comes from mouse F9 cells, which serve
as an in vitro model of embryonic stem cell differentiation. Here, RA promotes thyroid hormone
uptake through the transcriptional up-regulation of a thyroid hormone transporter gene (Mct8) [165].
It thus remains to be tested if the regulation of tooth formation by RA involves modulation of thyroid
hormone signaling.
6. Essential Roles for RA in Zebrafish Fin Regeneration
6.1. RA Controls Blastema Formation and Maintenance
The zebrafish caudal fin is a well-studied model for understanding the cellular and molecular
processes underlying fin growth and regeneration [166,167]. RA plays a general role in the normal
growth of lepidotrichia (segmented rays of dermal bone): As bones grow in post-embryonic fins,
RA is produced in fibroblasts and fosters the synthesis of bone matrix constituents from neighboring
osteoblasts. Excessive signaling by RA, as in experimental situations, is counteracted by expression of
cyp26b1 in osteoblasts. Thus synthesis and degradation of RA in growing fins are tightly regulated [168]
(Figure 3A).
Biomolecules 2019, 9, 860 13 of 25
Biomolecules 2019, 9, 860 13 of 26 
. 
Figure 3. RA orchestrates bone growth during fin development and osteoblast behavior in 
regenerating fins. (A) As the fins grow, RA is produced by fibroblasts and stimulates matrix 
deposition (dark grey, black interruptions represent segmental joints) from osteoblasts in growing fin 
rays of juvenile and adult fish. Osteoblasts control exposure to RA by expressing cyp26b1 at low 
enough concentrations to allow activation of bone matrix genes. (B) Immediately upon amputation, 
fibroblasts in undamaged stump tissue upregulate aldh1a2 expression and flood the distal wound 
with RA. Osteoblasts need to protect themselves from RA by expressing cyp26b1 in order to 
dedifferentiate to preosteoblasts and migrate into the blastema. (C) Regenerating fin rays set up an 
RA gradient that emanates from aldh1a2 expressing distal blastema fibroblasts and fades out 
proximally by cyp26b1 expressing proximal fibroblasts that act as a sink. Preosteoblasts divide in areas 
of high RA concentration and redifferentiate in areas below a certain RA threshold level. cyp26a1 
expression in cells of the proximal basal epithelial layer provides an RA-free niche that attracts 
preosteoblasts and allows end-to-end alignment of newly added osteoblasts with existing ones. 
Upon amputation, a proliferative blastema forms that consists of undifferentiated and 
proliferating cells that re-establish the fin and its skeleton. Precise control of the metabolism of RA 
and hence, the activity of RA signaling fulfills several important functions during regeneration. One 
of the first consequences of amputation is the elevated synthesis of RA through upregulation of 
aldh1a2 in the stump fibroblasts. RA is required and sufficient to boost proliferation of stump cells 
and induce expression of the target genes wnt10b and igf2b in an autocrine fashion, whereas full 
activation of fgf20a expression also relies on other signals. Together, these genes promote the 
formation of the blastema [169]. 
Several signaling pathways have been shown to be required to ensure robust proliferation of 
cells in the blastema. When RA signaling is experimentally inhibited, both blastemal and epithelial 
cells show reduced proliferation rates. This is likely to be due to the breakdown of a network of RA-
, FGF- and Wnt/β-catenin mediated signals that mutually stimulate each other’s activities. RA also 
down-regulates the growth-inhibitory effects of non-canonical Wnt signaling and thus is an integral 
part of the machinery that keeps the blastema in a proliferative state. Lastly, and in contrast to FGF, 
Wnt/β-catenin and Activin βA pathways, massive cell death is observed in cells of the blastema when 
the availability of RA is reduced [169], indicating that RA prevents cell death in a rapidly dividing 
tissue type. Regeneration of the zebrafish skeleton involves a substantial contribution from 
Figure 3. RA orchestrates bone growth during fin development and osteoblast behavior in regenerating
fins. (A) As the fins grow, RA is produced by fibroblasts and stimulates matrix deposition (dark grey,
black interruptions represent segmental joints) from osteoblasts in growing fin rays of juvenile and
adult fish. Osteoblasts control exposure to RA by expressing cyp26b1 at low enough concentrations to
allow activation of bone matrix genes. (B) Immediately upon amputation, fibroblasts in undamaged
stump tissue upregulate aldh1a2 expression and flood the distal wound with RA. Osteoblasts need
to protect themselves from RA by expressing cyp26b1 in order to dedifferentiate to preosteoblasts
and migrate into the blastema. (C) Regenerating fin rays set up an RA gradient that emanates from
aldh1a2 expressing distal blastema fibroblasts and fades out proximally by cyp26b1 expressing proximal
fibroblasts that act as a sink. Preosteoblasts divide in areas of high RA concentration and redifferentiate
in areas below a certain RA threshold level. cyp26a1 expression in cells of the proximal basal epithelial
layer provides an RA-free niche that attracts preosteoblasts and allows end-to-end alignment of newly
added osteoblasts with existing ones.
Upon amputation, a proliferative blastema forms that consists of undifferentiated and proliferating
cells that re-establish the fin and its skeleton. Precise control of the metab lism o RA and hence,
the activity of RA signaling fulfills sev ral important functions during regeneration. One of the first
co sequences of amputation i the elevated synth sis of RA hrough upregulation of aldh1a2 in the
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fgf20a expr ssion al o relies on oth r signals. Together, these genes pr mot the f rmation of the
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Several signaling pathways have been shown to be required to ensure robust proliferation of
cells in the b astema. When RA ignaling is experimentally inhibited, both blastemal and epithelial
cells show reduced proliferation rates. This is likely to be due to the breakdown of a network of RA-,
FGF- and Wnt/β-catenin med ated signals that mutually stimulate each other’s activities. RA also
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dividing tissue type. Regeneration of the zebrafish skeleton involves a substantial contribution from
differentiated osteoblasts. In contrast, bone repair in mammals relies predominantly on mesenchymal
stem cells [170]. Nonetheless, a thorough understanding of the dedifferentiation process in zebrafish
osteoblasts informs efforts to improve bone healing in mammalian bone tissue.
6.2. Local Degradation of RA Controls Morphogenetic Processes of Osteoblasts and Osteoclasts
Osteoblasts in the regenerating fin are replenished from existing osteoblasts in the stump area
and from a reserve population of osteoblast precursor cells [140,171]. Bone-forming osteoblasts are
required to dedifferentiate before they become proliferative and migrate into the blastema [172–174].
During this process, differentiation markers are down-regulated and markers of immature osteoblasts
are up-regulated. However, because high RA levels inhibit the dedifferentiation of osteoblasts to
a proliferative preosteoblast state, osteoblast protect themselves from the effects of high local RA
concentrations by rapid upregulation of the RA-degrading enzyme Cyp26b1, and this upregulation
is not dependent on RA [168]. The inhibition of RA signaling in osteoblasts is thus one of the first
mechanisms to be identified that regulates dedifferentiation during regeneration. Once preosteoblasts
have migrated into the blastema, cyp26b1 expression is shut down (Figure 3B). aldh1a2 expression in
the distal tip of the blastema provides a rich source of RA that supports blastemal proliferation and
inhibits the redifferentiation of preosteoblasts.
As the proliferating blastema is displaced distally, fibroblasts in the proximal blastema express
cyp26b1, thus acting as a sink that sharpens a distal-to-proximal RA gradient. The concept that
Cyp26 enzymes can have cell non-autonomous consequences on RA levels within tissues has most
clearly been demonstrated in experimental situations where cells reporting RA signaling lost the
reporter signal when being transplanted into an environment of high Cyp26 activity, but not when
surrounded by cells with low Cyp26 activity [27]. The principle has physiological importance,
for example, during the formation of straight boundaries between rhombomeres (transiently forming
segments) in the zebrafish hindbrain: When cells from rhombomeres (r) r3 or r5 intermingle with
cells from an adjacent rhombomere during initial boundary development, higher Cyp26 expression
in even-numbered rhombomeres subdues RA signaling in the stray cells and switches their identity
to the appropriate fate [175]. Eventually, preosteoblasts align with osteoblasts in the most proximal
blastema and redifferentiate into osteoblasts that extend the existing bone distally. These processes
are triggered by an increase in distance between the RA source in the distal blastema and proximal
preosteoblasts. In this environment, the concentration of RA falls below a threshold that allows
osteoblast redifferentiation [168]. This elegant mechanism ensures a gradient of cells experiencing high
and low levels of RA that allow the processes of proliferation (for the production of all cells that replace
the lost structure) and redifferentiation of osteoblasts to run in parallel (Figure 3C).
Re-formed osteoblasts have to accurately align with existing skeletal structures. To achieve this,
preosteoblasts proliferate locally under the influence of a proximally restricted source of Shha that
originates in the epidermis [176]. In order for shha to be transcribed, proximal parts of the basal
epidermal layer have to be cleared from RA, which is achieved through the expression of another Cyp26
gene, cyp26a1(Figure 3C). An experimentally induced loss of RA clearance results in seemingly random
migration of osteoblasts into interray or even stump tissue. Osteoblasts may themselves exert a piloting
function for other cell types, as the breakdown of ray–interray boundaries also affects other cell types,
like fibroblasts and blood vessels [176]. An excess of RA results in a similar phenotype and induces an
over-mineralized phenotype, by promoting bone matrix synthesis in osteoblasts [177]. Suppression
of RA signaling by removing RA locally, as observed in the stump and in the proximal blastema,
is a mechanism repeatedly utilized to guide osteoblast behavior towards the correct regenerative
morphogenetic processes. Experimentally elevated RA levels during osteoblast differentiation in
regenerating fins also results in irregularly shaped hemirays [168]. This finding led to the observation
that regeneration of new bone is accompanied by osteoclasts accumulating at the inner and outer
surfaces of newly forming bone matrix. Although RA is known to inhibit the differentiation of
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osteoclasts [40,178,179], RA levels are low enough in the proximal blastema for osteoclasts to remove
excess matrix to define the final shape of new hemirays.
6.3. RA Controls Cell Fate in the Preosteoblast Lineage
Another interesting role for RA has been identified in controlling cell fate choice in the preosteoblast
lineage [180]. The fin ray skeleton is formed by osteoblasts and is subdivided by bone articulations,
or joints, at regular intervals. Joints are formed during growth, and reformed during regeneration, by a
distinct cell type—the joint-forming osteoblasts. These are aligned in two rows, one each on either side
of a new articulation [181]. Joint-forming osteoblasts and (regular) osteoblasts originate from a common
preosteoblast cell lineage [180]. Preosteoblasts that express runx2a/b differentiate into osteoblasts,
while those expressing evx1, hoxa13 and pthlha become committed to forming joint cells. RA treatment
during regeneration suppresses joint cell markers. The effect might act directly on joint cells, since they
express the RA-receptor rargb and because mature joint-forming osteoblasts down-regulate expression
of their lineage markers under RA-treatment. Prolonged RA-exposure of mature fin rays also leads
to the appearance of new osteoblasts in the joints. Reporter gene analyses showed that the fate of
mature joint-forming osteoblast is not fixed, instead they differentiate to (regular) osteoblasts under
RA, presumably by lifting an arrest in osteoblast differentiation or by transdifferentiation. If this effect
contributes significantly to the over-ossification observed in RA-treated regenerates [176,177] has not
been established yet. The findings underscore once more the requirement for precise spatio-temporal
control of RA signaling during fin growth and regeneration.
6.4. Growth Control Upstream of RA in Zebrafish Fins
Proximal parts of the caudal fin regenerate faster and with a proportionately larger blastema than
more distally located parts, a mechanism that allows the regenerative growth of proximally injured
parts of the fin to catch up with the distal edge. This phenomenon is known as allometric growth and
contrasts with isometric growth, which preserves proportional relationships in a growing organism.
Fin growth rates are controlled by the protein phosphatase Calcineurin. When the Calcineurin inhibitor
FK506 is applied to the regenerating fin, it switches to allometric growth mode, typical for proximal
regeneration. Thus, the role of active Calcineurin signaling is to enable a slower, isometric growth
rate [182]. Calcineurin exerts its effect on regeneration rates by negatively controlling RA signaling.
When Calcineurin is inhibited, aldh1a2 expression as well as rarg and crabp2b, which binds RA and
increases RA availability to nuclear receptors [183], are up-regulated in the blastema, even prior to
visible proximal allometric regeneration [182]. Conversely, genes involved in the degradation of RA
signaling, cyp26a1, cyp26c1 and crabp2a, which transports RA to Cyp26 enzymes for degradation [28],
are down-regulated in the blastema when Calcineurin is inhibited. Increased RA signaling has been
shown to increase proliferation rates in the blastema [169]. Calcineurin directly regulates members of
the NFAT transcription factor family [184], but another target has been identified in fins that control
RA-mediated growth. The another long fin (alf) mutant develops with overgrown fins that have elongated
skeletal segments, a phenotype that is indistinguishable from FK506-treated fins. alf encodes the
two-pore domain potassium (K+) channel Kcnk5b [185] and is thought to be a gain-of-function mutant,
because loss-of-function mutants in kcnk5b possess and regenerate normal fins without overgrowth.
Together, this suggests that Calcineurin might act to inactivate Kcnk5b. Calcineurin is thought to bind
to the Kcnk5b C-terminus that, when mutated, results in Kcnk5b losing sensitivity to Calcineurin.
Mutants that lead to the loss of the last transmembrane domain, which also harbors the point mutation
in alf, and the C-terminal end result in overgrowth phenotypes. How changes in the membrane
potential of fin tissue affect RA signaling activity remains to be examined.
Does RA control position in the zebrafish fin or does it control growth rates? Because of the
proximalizing activity that RA exerts on regenerating limbs in salamanders [186,187] and the fact
that fin ray bifurcations (as presumed markers of proximo-distal identity) are shifted distally in
RA-treated regenerates [188,189], RA was believed to control proximal identity in the fin. However,
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FK506 treatment, which leads to upregulation of RA signaling, does not proximalize fins, because
removal of the drug results in an immediate stop of regenerative growth rather than continuation of
an allometric growth program (which would be expected if the fin was proximalized) [190]. Instead,
accelerated growth requires the continued presence of the drug. Also, fins that regenerated under the
influence of FK506 to a larger fin do not regenerate to the enlarged size when resectioned without the
presence of FK506. It is most likely, therefore, that RA signaling activity controls growth rates rather
than positional values.
7. Conclusions
Research into RA signaling in development remains a highly productive field that experiences
continuous advances and has led to an enhanced understanding of the underlying mechanisms
and principles. One principle that continues to resurface in various contexts is the formation
of morphogen gradients of RA that determine cell fate decisions in a concentration-dependent
manner. Prominent examples that are well characterized include the hindbrain, placode- and neural
crest-derived craniofacial structures as well as the paraxial mesoderm and neural tube [5,21,191,192].
During vertebrate trunk development, newly generated mesodermal cells synthesize RA, which, in a
gradient opposing that of Wnt signals, determines the rate at which NMPs are produced and induces
neural differentiation. Cyp26a1 is expressed dynamically in the caudal-most region that includes the
NMPs and keeps RA at a low concentration, which is an absolute requirement for the differentiation
of NMPs to the mesodermal lineage. RA signaling thus coordinates the production of neural and
mesodermal tissue. Local sources and sinks of RA have also been identified in the regenerating
zebrafish fin, where fibroblasts of the proliferating blastema in the distal regenerate provide a source of
RA, while fibroblasts in the proximal regenerate express cyp26b1. Preosteoblasts in the emergent RA
gradient proliferate distally in a “high RA” environment and redifferentiate proximally to osteoblasts
in a “low RA” environment. As in the vertebrate trunk, the RA gradient is highly dynamic, in that
it advances distally and leaves new osteoblasts in its wake that rebuild the fin ray skeleton. Local
gradients of RA may also underlie the extent of tooth initiation in the pharyngeal region of zebrafish,
since RA treatments initiate the formation of ectopic teeth in anterior and dorsal pharyngeal positions.
However, the responsible sources and sinks remain to be characterized in more detail.
Another important principle is that Cyp26 activity in one cell type can act as a local sink to
keep RA below a threshold concentration in a neighboring cell type. We reviewed examples during
vertebrae development in zebrafish, where RA induces a reiterative pattern of axial entpd5a/cyp26b1
expression in chordoblasts, which eventually causes a segmented mineralization of the notochord
sheath and formation of chordacentra. Here, expression of cyp26b1 acts as a sink for RA that apparently
keeps neighboring areas, the future intervertebral discs, RA-free and thus prevents mineralization.
It should be noted, however, that the exact sources for RA remain to be resolved in future studies.
The RA gradient in the regenerating zebrafish fin serves as another example for non-autonomous
loss of RA signaling, because cyp26b1 expressing fibroblasts eliminate RA from their environment
to allow neighboring preosteoblasts to drop out of the cell-cycle and differentiate again. Finally,
fin regeneration also presented examples where cells use cell-autonomous inhibition of RA signaling to
protect themselves from unwanted effects in a “high RA” environment: Basal epidermal cells eliminate
residual RA to ensure appropriate signaling activities that attract osteoblasts by expressing cyp26a1 and
stump osteoblasts express cyp26b1 to undergo dedifferentiation in an otherwise proliferation-enhancing
environment rich in RA, where both processes are mutually exclusive for osteoblasts. Ongoing
efforts from mammalian and non-mammalian vertebrate model systems are expected to shed light on
RA signaling from a developmental and evolutionary point of view. The work in zebrafish, whose
developmental mechanisms do not always closely match those in tetrapods, sheds light on the scope
of evolutionary modifications that changes in RA-mediated gene regulation has facilitated. It is also
informative with regard to identifying developmental processes that may have been overlooked in
mammalian model systems.
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